Business involving high tech, life sciences and biotech

Austrianova is one organization that does deals that links high tech, life sciences and biotech. It is combined with an encapsulation technology with the living cells in bio-inery polymers. In short, we are a life science associated business that concentrate in the insertion of living cells or bacteria in small capsules for defense which is also known as cell encapsulation technology, isolation, storage and transportation. We were first established in the year 2007 and was based in Singapore's top exploration biotech hub, Biopolis that has worldwide vision in providing encapsulation services like micro encapsulation.

There is a quick advancing area of liking in healthy maintenance and more specifically, in the subject of neutraceuticals which is the understanding and use of probiotic bacteria. Therefore, probiotics encapsulation was built. The cell-in-a-box technology was formed by Austranova with the vision to keep safe, separate, collect and deliver living cells. This advanced equipment can be used for several reasons and can be operated to probiotics, cosmetics and agriculture environmental protection and watching as well as creating the root of a authoritative research instrument.

In healthcare, this skill helps controloperate secure attaching of cells or stem cells such as cell therapy, involving them isolated from the immune system and permitting long term making of therapeutic molecules in patients. In biotechnology, the cell-in-a-box procedure guards cells in bioreactors and fermentors and at the same time, it make easier purification of bioproducts manufactured from the cells and it reduces manufacture cost too.

A wide gauge cGMP facility for the making of biomedical grade encapsulated cell products was used to effectively created and right now, Austrianova is in the journey of making this ability in the whole of SE Asia. This means the use of cell-in-a-box was quite a success for ancreatic cancer! Basically, it is the use of encapsulated cells for cancer cell therapy from genetically modified cells over-expressing a chemo-activating enzyme to give lower amounts of chemotherapy to be used more efficaciously without the casual enervating side effects. The encapsulated cell are sited, using supraselective catheterisation, into blood vessels that flows to the tumor where they locally convert a chemotherapeutic product to its tumor toxic product.

Comments? Questions? Email Here

© HowtoAdvice.com